Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    3 1
    Investigated Drugs:
    Bulgaria Czechia Denmark Estonia France Germany +12
  • Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

    Not recruiting

    2 1 1
    Belgium France Germany Greece Italy The Netherlands +2
  • Study on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma

    Not recruiting

    1 1 1 1
    France Spain
  • Study of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Not recruiting

    4 1 1 1
    Czechia Finland France Germany Greece Italy +3
  • Study on the Safety and Efficacy of PF-06835375 and Diphenhydramine Hydrochloride for Adults with Moderate to Severe Primary Immune Thrombocytopenia

    Not recruiting

    2 1 1 1
    Czechia Hungary Poland
  • Study on the Effects of Amlodipine and Irbesartan in Patients with High Blood Pressure

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Greece
  • Study of Zolbetuximab with Nab-Paclitaxel and Gemcitabine for Adults with Metastatic Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France Ireland Italy Spain
  • Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +6
  • Study Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Belgium Denmark France Germany Greece Italy +4
  • Study on the Long-Term Safety of Sacituzumab Govitecan for Patients with Metastatic Solid Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Spain